| 发明名称 |
Methods of cancer treatment using naaladase inhibitors |
| 摘要 |
This use of a pharmaceutically acceptable amount of a NAALADase inhibitor (especially o-phenanthroline, EGTA, EDTA, quisqualic acid or b-NAAG) is for preparing a medicament for treating cancer or inhibiting cell growth in an animal. |
| 申请公布号 |
NZ333235(A) |
申请公布日期 |
2000.06.23 |
| 申请号 |
NZ19970333235 |
申请日期 |
1997.06.13 |
| 申请人 |
GUILFORD PHARMACEUTICALS INCORPORATED |
发明人 |
SLUSHER, BARBARA S;JACKSON, PAUL F;TAYS, KEVIN L;MACLIN, KEITH M |
| 分类号 |
A61K45/00;A61K31/00;A61K31/66;A61K31/665;A61K31/67;A61K31/675;A61K38/00;A61K38/05;A61P35/00;A61P43/00;C07F9/30;C07F9/38 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
